Research And Development
Biotechnology
Biopharmaceutical

BioCryst

10,398

$2.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.50%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell BioCryst and other stocks, options, ETFs, and crypto commission-free!

About BCRX

BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. Read More The company was founded in 1986 and is headquartered in Durham, NC.

CEO
Jon P. Stonehouse
Employees
140
Headquarters
Durham, North Carolina
Founded
1986
Market Cap
294.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
6.97M
High Today
$2.07
Low Today
$1.93
Open Price
$1.97
Volume
4.04M
52 Week High
$9.26
52 Week Low
$1.38

Collections

Research And Development
Biotechnology
Biopharmaceutical
Pharmaceutical
Health
Technology
US
North America

BCRX News

ReutersMar 26

Edited Transcript of BCRX earnings conference call or presentation 5-Mar-20 1:30pm GMT

Q4 2019 BioCryst Pharmaceuticals Inc Earnings Call BIRMINGHAM Mar 26, 2020 (Thomson StreetEvents) -- Edited Transcript of BioCryst Pharmaceuticals Inc earnings
434

BCRX Earnings

-$0.34
-$0.23
-$0.11
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 6, Pre-Market

People Also Bought

Inovio

224,604

$7.59

-5.36%

Inovio

224,604

$7.59

-5.36%

Catalyst Pharmaceuticals

76,623

$3.85

-0.77%

Plug Power

255,381

$3.49

-2.51%

Novavax

38,483

$14.75

+3.15%

You May Also Like

WSBF
QWLD
GVP
VOLT
RELV
POAI
LDUR
SCHG
SMDY
ASB-D
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy BCRX

Market Price$2.00
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell BioCryst stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up